These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37191984)

  • 1. Pulmonary fibrosis in COVID-19: mechanisms, consequences and targets.
    O'Reilly S
    QJM; 2023 Oct; 116(9):750-754. PubMed ID: 37191984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients.
    Giacomelli C; Piccarducci R; Marchetti L; Romei C; Martini C
    Biochem Pharmacol; 2021 Nov; 193():114812. PubMed ID: 34687672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unravels the Influences of SARS-CoV-2 Infections to Cancer Patients.
    Chen Y; Qin Y; Fu Y; Gao Z; Deng Y
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healing after COVID-19: are survivors at risk for pulmonary fibrosis?
    McDonald LT
    Am J Physiol Lung Cell Mol Physiol; 2021 Feb; 320(2):L257-L265. PubMed ID: 33355522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?
    Michalski JE; Kurche JS; Schwartz DA
    Transl Res; 2022 Mar; 241():13-24. PubMed ID: 34547499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary fibrosis in patients with COVID-19: A review].
    Chuchalin AG
    Ter Arkh; 2022 Dec; 94(11):1333-1339. PubMed ID: 37167174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection.
    Venkataraman T; Coleman CM; Frieman MB
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28404843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential mechanisms for lung fibrosis associated with COVID-19 infection.
    Parimon T; Espindola M; Marchevsky A; Rampolla R; Chen P; Hogaboam CM
    QJM; 2023 Jul; 116(7):487-492. PubMed ID: 36018274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts.
    John AE; Joseph C; Jenkins G; Tatler AL
    Immunol Rev; 2021 Jul; 302(1):228-240. PubMed ID: 34028807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Findings on Cell-Based Therapies for COVID19-Related Pulmonary Fibrosis.
    Chuang HM; Ho LI; Harn HJ; Liu CA
    Cell Transplant; 2021; 30():963689721996217. PubMed ID: 33845643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the ACE2/Ang-(1-7)/MasR Axis in Pulmonary Fibrosis: Implications for COVID-19.
    Morganstein T; Haidar Z; Trivlidis J; Azuelos I; Huang MJ; Eidelman DH; Baglole CJ
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung recovery with prolonged ECMO following fibrotic COVID-19 acute respiratory distress syndrome.
    Kazi AW; Summer R; Sundaram B; George G
    Am J Med Sci; 2023 Mar; 365(3):307-312. PubMed ID: 36535539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target.
    Ntatsoulis K; Karampitsakos T; Tsitoura E; Stylianaki EA; Matralis AN; Tzouvelekis A; Antoniou K; Aidinis V
    Front Immunol; 2021; 12():687397. PubMed ID: 34671341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research advances in the mechanism of pulmonary fibrosis induced by coronavirus disease 2019 and the corresponding therapeutic measures].
    Wang J; Wang BJ; Yang JC; Wang MY; Chen C; Luo GX; He WF
    Zhonghua Shao Shang Za Zhi; 2020 Aug; 36(8):691-697. PubMed ID: 32174095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals.
    Al-Kuraishy HM; Batiha GE; Faidah H; Al-Gareeb AI; Saad HM; Simal-Gandara J
    Inflammopharmacology; 2022 Dec; 30(6):2017-2026. PubMed ID: 36044102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and Molecular Mechanism of Pulmonary Fibrosis Post-COVID-19: Focus on Galectin-1, -3, -8, -9.
    Oatis D; Simon-Repolski E; Balta C; Mihu A; Pieretti G; Alfano R; Peluso L; Trotta MC; D'Amico M; Hermenean A
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis.
    Venkataraman T; Frieman MB
    Antiviral Res; 2017 Jul; 143():142-150. PubMed ID: 28390872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Pathogenesis of Fibrosis, Thrombosis and Surfactant Dysfunction in the Lungs of Severe COVID-19 Patients.
    Krygier A; Szmajda-Krygier D; Świechowski R; Pietrzak J; Wosiak A; Wodziński D; Balcerczak E
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus infection induced pulmonary fibrosis.
    Huang WJ; Tang XX
    J Transl Med; 2021 Dec; 19(1):496. PubMed ID: 34876129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing incidence of lung transplantation in patients with post-COVID-19 pulmonary fibrosis.
    Khajotia R
    Pan Afr Med J; 2021; 40():169. PubMed ID: 34970411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.